2 g / day. evening, increasing the dose according to clinical response to 1 tab. Indications for use drugs: treatment of moderate urination disorders caused by benign prostatic hyperplasia. Indications for use drugs: hypertension (as monotherapy and in combination with other drugs), symptomatic treatment of benign prostatic hyperplasia. Method of lively of drugs: Table., Coated lively 5 mg. lively and Administration of drugs: used exclusively for the treatment of men; common dose - 5 mg / day, regardless of the meal, at least for 6 months in the treatment lively elderly patients, no need for lively reduction, while elimination of finasteride is slowed down slightly (about 8 h), lively kidney disease do not need to decrease dosage. Pharmacotherapeutic group: G04SH01 - different nutrient preparations. Method of production of drugs: Table. MDD - 20 mg for patients with renal failure and elderly dose correction is needed. Side effects and complications in the use of drugs: nausea, abdominal pain, rash, swelling of the skin, gynecomastia is reversible. Indications for use lively benign prostatic lively in order to reduce the size of the prostate gland and therefore reduce the symptoms of dysuria. The main pharmaco-therapeutic effects: No Regular Medications obstruction of the lower urethra tract, facilitates the emptying of bladder, reducing the selection pressure and increases the volume of lively causing an urge to urinate, reduces residual urine volume. Contraindications to the use of drugs: hypersensitivity to oxybutynin or one of the fillers, the risk of urinary retention associated with diseases of the urethra and prostate, bowel obstruction, toxic mehakolon, intestinal atony, severe ulcerative colitis, myasthenia gravis, glaucoma vuzkokutova or shallow here chamber of the eye. The main pharmaco-therapeutic effects: inhibits proliferation of prostate fibroblasts stimulated by b-FGF (basic fibroblast growth factor), inhibits the growth of connective tissue in the prostate and prevents its fibrosis. Pharmacotherapeutic group: G04BD07 - antispasmodic remedies that relax smooth muscle of blood vessels, bronchi and other internal organs. Side effects and complications in the use of drugs: nausea, constipation, diarrhea, there is a risk of hypersensitivity reactions (anaphylactic shock, urticaria). Indications for use drugs: urinary incontinence, urgency to urinate and polakiuriya (intensive urination) in cases of unstable bladder lively neurogenic origin or due to idiopathic detrusor instability features, night enuresis in children (aged 5 years). Dosing and Administration of drugs: used internally to 4 Table / day during meals, duration of treatment is determined individually. Method of production of drugs: Table., Film-coated, to 80 mg. Method of production of drugs: Table. Pharmacotherapeutic group: G04CA03 - alpha-blocker. Pharmacotherapeutic group: G04BD04 - antispasmodic remedies that relax smooth muscle of blood vessels, bronchi and other internal organs. Pharmacotherapeutic group: G04CX02 - lively used to treat cancer.
0 件のコメント:
コメントを投稿